BCL2 and cancer: After correcting for multiple testing, the only significant promoters were TERT in cutaneous melanoma and pan-cancer; BCL7A, IGLL5, BCL2, and POLR3E pan-cancer; and HNRNPR in uterine adenocarcinoma (Supplementary Data 6).